Structural and Functional Studies of Bacterial Enolase, a Potential Target against Gram-Negative Pathogens.
Anti-Bacterial Agents
/ chemistry
Calorimetry
Catalytic Domain
Crystallography, X-Ray
Drug Evaluation, Preclinical
Enzyme Inhibitors
/ chemistry
Escherichia coli Proteins
/ antagonists & inhibitors
Gram-Negative Bacteria
/ drug effects
Microbial Sensitivity Tests
Molecular Docking Simulation
Phosphopyruvate Hydratase
/ antagonists & inhibitors
Protein Conformation
Structure-Activity Relationship
Tropolone
/ chemistry
Journal
Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623
Informations de publication
Date de publication:
05 03 2019
05 03 2019
Historique:
pmc-release:
05
03
2020
pubmed:
5
2
2019
medline:
27
11
2019
entrez:
5
2
2019
Statut:
ppublish
Résumé
Enolase is a glycolytic metalloenzyme involved in carbon metabolism. The advantage of targeting enolase lies in its essentiality in many biological processes such as cell wall formation and RNA turnover and as a plasminogen receptor. We initially used a DARTS assay to identify enolase as a target in Escherichia coli. The antibacterial activities of α-, β-, and γ-substituted seven-member ring tropolones were first evaluated against four strains representing a range of Gram-negative bacteria. We observed that the chemical properties and position of the substituents on the tropolone ring play an important role in the biological activity of the investigated compounds. Both α- and β-substituted phenyl derivatives of tropolone were the most active with minimum inhibitory concentrations in the range of 11-14 μg/mL. The potential inhibitory activity of the synthetic tropolones was further evaluated using an enolase inhibition assay, X-ray crystallography, and molecular docking simulations. The catalytic activity of enolase was effectively inhibited by both the naturally occurring β-thujaplicin and the α- and β-substituted phenyl derivatives of tropolones with IC
Identifiants
pubmed: 30714720
doi: 10.1021/acs.biochem.8b01298
pmc: PMC6511404
mid: NIHMS1022662
doi:
Substances chimiques
Anti-Bacterial Agents
0
Enzyme Inhibitors
0
Escherichia coli Proteins
0
Tropolone
7L6DL16P1T
Phosphopyruvate Hydratase
EC 4.2.1.11
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1188-1197Subventions
Organisme : NIGMS NIH HHS
ID : P41 GM103393
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI140734
Pays : United States
Références
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
Biocontrol Sci. 2007 Sep;12(3):101-10
pubmed: 17927050
J Chem Theory Comput. 2016 Jan 12;12(1):281-96
pubmed: 26584231
Medchemcomm. 2016 Sep 1;7(9):1783-1788
pubmed: 28093576
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;270(1-2):160-70
pubmed: 3223137
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2251-6
pubmed: 22308350
Chem Commun (Camb). 2013 Apr 21;49(31):3197-9
pubmed: 23482955
Methods Mol Biol. 2015;1263:287-98
pubmed: 25618353
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1667-72
pubmed: 17242352
Cell Mol Life Sci. 2001 Jun;58(7):902-20
pubmed: 11497239
Biol Pharm Bull. 2003 Oct;26(10):1487-90
pubmed: 14519960
J Med Chem. 2008 May 22;51(10):2871-8
pubmed: 18260614
J Biomed Biotechnol. 2012;2012:156795
pubmed: 23118496
Int J Genomics. 2015;2015:395753
pubmed: 25977913
Sci Rep. 2015 Oct 16;5:15337
pubmed: 26471247
Ann N Y Acad Sci. 1974 May 10;235(0):364-86
pubmed: 4605290
ACS Med Chem Lett. 2013 Jun 10;4(8):757-61
pubmed: 24900743
Nat Prod Rep. 2008 Feb;25(1):118-38
pubmed: 18250899
Biochemistry. 2011 Jun 21;50(24):5477-86
pubmed: 21598903
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Org Biomol Chem. 2012 Nov 21;10(43):8597-604
pubmed: 23032214
ACS Chem Biol. 2013;8(6):1271-82
pubmed: 23547795
Pharm Pat Anal. 2012 May;1(2):207-21
pubmed: 24163736
J Mol Biol. 2006 Apr 21;358(1):8-15
pubmed: 16516921
Curr Opin Infect Dis. 2010 Dec;23(6):546-53
pubmed: 20802331
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21984-9
pubmed: 19995983
Biol Pharm Bull. 2002 Aug;25(8):981-5
pubmed: 12186430
Nat Chem Biol. 2016 Dec;12(12):1053-1058
pubmed: 27723749
Sci Rep. 2017 Mar 08;7:44186
pubmed: 28272459
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Drug Discov Today. 2003 Oct 1;8(19):876-7
pubmed: 14554012
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):271-81
pubmed: 21460445
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692